XSpray Pharma AB

Research XSpray Pharma AB (XSPRAY) on Bullrun: market cap SEK 495.98M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerXSPRAY
ExchangeST
CountrySweden
SectorHealthcare
IndustryBiotechnology
CurrencySEK
Market capSEK 495.98M
Financial periodQ2 2026
RevenueSEK 0
Net income-SEK 39.78M
Free cash flow-SEK 47.25M

Valuation Snapshot

latest market cap is SEK 495.98M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	n/a	n/a	n/a	n/a	-5.41	SEK 153.75M	SEK 148.39M	SEK 604.65M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-23	SEK 495.98M	n/a	n/a	n/a

About XSpray Pharma AB

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the treatment of chronic myeloid leukemia (CML)and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib for the treatment of CML; XS008, an axitinib for the treatment of kidney cancer;

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

Camurus AB (0RD1) Flerie AB (publ) (1NP1) GENOVIS AB SE-40 (5GV) Fluicell AB (publ) (5J90) ExpreS2ion Biotech Holding AB (publ) (5JD0) ALZINOVA AB (78D) 7AL0 (7AL0) ASCELIA PHARMA AB (7ZA) Biosergen AB (8N10) ABERA BIOSCIENCE AB (8WK) Ascelia Pharma AB (publ) (ACE) AcouSort AB (ACOU)

Frequently asked questions

What is XSpray Pharma AB's market cap?

XSpray Pharma AB's market capitalization is SEK 495.98M.